2022
DOI: 10.1007/s11606-021-07302-6
|View full text |Cite
|
Sign up to set email alerts
|

The Heart and Cannabis (THC) Cohort: Differences in Baseline Health and Behaviors by Cannabis Use

Abstract: Background Evidence on the cardiovascular health effects of cannabis use is limited. We designed a prospective cohort study of older Veterans (66 to 68 years) with coronary artery disease (CAD) to understand the cardiovascular consequences of cannabis use. We describe the cohort construction, baseline characteristics, and health behaviors that were associated with smoking cannabis. Objective To understand the cardiovascular consequences of cannabis use. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 34 publications
0
1
0
Order By: Relevance
“…Electrocardiogram tracings were linked to cardiologist ECG interpretations, patient demographic characteristics (age, sex, and race and ethnicity), and comorbidity information (AF; heart failure; hypertension; diabetes; prior cerebrovascular accident [CVA], transient ischemic attack [TIA], or thromboembolism [TE]; prior myocardial infarction [MI]; peripheral vascular disease; and chronic kidney disease) from the VA Corporate Data Warehouse. Comorbidities were determined using International Statistical Classification of Diseases and Related Health Problems, Tenth Revision and Current Procedural Terminology codes . Using comorbidity fields, we estimated the CHA 2 DS 2 -VASc (congestive heart failure, hypertension, age, diabetes mellitus, prior stroke or transient ischemic attack or thromboembolism, vascular disease, age, sex category) scores.…”
Section: Methodsmentioning
confidence: 99%
“…Electrocardiogram tracings were linked to cardiologist ECG interpretations, patient demographic characteristics (age, sex, and race and ethnicity), and comorbidity information (AF; heart failure; hypertension; diabetes; prior cerebrovascular accident [CVA], transient ischemic attack [TIA], or thromboembolism [TE]; prior myocardial infarction [MI]; peripheral vascular disease; and chronic kidney disease) from the VA Corporate Data Warehouse. Comorbidities were determined using International Statistical Classification of Diseases and Related Health Problems, Tenth Revision and Current Procedural Terminology codes . Using comorbidity fields, we estimated the CHA 2 DS 2 -VASc (congestive heart failure, hypertension, age, diabetes mellitus, prior stroke or transient ischemic attack or thromboembolism, vascular disease, age, sex category) scores.…”
Section: Methodsmentioning
confidence: 99%